Plandaí Biotechnology, Inc. Announces Favorable Anti-Malaria Test Results In … – MarketWatch
By Dr. Matthew Watson
Plandaí Biotechnology, Inc. Announces Favorable Anti-Malaria Test Results In ... MarketWatch SEATTLE, WA--June 20, 2013--Plandaí Biotechnology, Inc. (otcqb:PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced the results of further in vitro testing ... |
Uncategorized
Comments Off on Plandaí Biotechnology, Inc. Announces Favorable Anti-Malaria Test Results In … – MarketWatch |
June 23rd, 2013
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research